心理治疗干预改善反复自伤者生活质量及其他结局的随机对照试验:FReSH START研究方案
FReSH START是一项多中心、个体1:1随机对照试验,评估标准治疗联合心理治疗与单独标准治疗对急诊就诊的反复自伤成人(≥18岁)的临床与成本效果。计划招募630名参与者,干预组接受三种改编疗法之一,疗程最长6个月,共12次每周一次、每次45-50分钟的一对一会谈。主要结局为随机化后12个月时由临床常规评估结局指标测量的生活质量。
要点
- FReSH START为多中心1:1随机对照试验,计划招募630名反复自伤成人。
- 干预组在标准治疗基础上接受心理动力人际治疗、认知行为治疗或接纳承诺疗法之一。
- 主要结局为随机化后12个月时临床常规评估结局指标测量的生活质量。
核心结论
- 该研究方案旨在探究改编疗法对反复自伤者是否具有成本效果并改善其生活质量。
研究设计与样本
- FReSH START为多中心、个体1:1随机对照试验,评估标准治疗联合心理治疗与单独标准治疗的临床与成本效果。
- 研究对象为在急诊科就诊的反复自伤成人(≥18岁),计划招募630名参与者,包含内部预试验、经济学评价和过程评价。
关键数值与推荐
- 干预组接受三种改编疗法之一(心理动力人际治疗、认知行为治疗或接纳承诺疗法),根据治疗师分配决定,疗程最长6个月,共12次每周一次、每次45-50分钟的一对一会谈。
- 主要结局为随机化后12个月时由临床常规评估结局指标测量的生活质量。
- 次要结局包括自杀意图、抑郁和成本效果。
- 数据通过医院就诊记录及随机化后6个月和12个月的在线/邮寄/电话问卷收集,资源使用额外在3个月和9个月时收集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Self-harm is a major public health challenge, and repeated self-harm is common in those attending hospital following an episode. Evidence suggests psychological interventions could help people who self-harm, but few definitive studies have assessed their clinical and cost-effectiveness. Repeated self-harm is associated with poor quality of life, depression, suicide and increased health service costs which justify the development of psychotherapeutic interventions tailored for people with repeated self-harm. METHODS: FReSH START is a multicentre individually 1:1 randomised controlled trial evaluating the clinical and cost-effectiveness of standard care plus psychological therapy or standard care alone for adults (≥ 18 years) presenting at an emergency department (ED) with repeated self-harm. Recruiting 630 participants, it includes an internal pilot, economic evaluation and process evaluation. The intervention will be delivered by mental health staff working in acute settings, with experience of assessing and managing risk in people presenting to emergency services with self-harm. Staff will be trained and supervised to deliver one of three specially adapted therapies: psychodynamic interpersonal therapy, cognitive behavioural therapy or acceptance and commitment therapy. Participants allocated to the intervention will receive one of the adapted therapies according to therapist allocation for up to 6 months via 12 weekly, one to one, 45-50-min sessions. The primary outcome is quality of life measured by the Clinical Outcomes in Routine Evaluation Outcome Measure at 12 months post-randomisation. Secondary outcomes include suicidal intent, depression and cost-effectiveness. Data are collected using hospital attendance records and online/postal/telephone questionnaires at 6 and 12 months post-randomisation, with resource use additionally collected at 3 and 9 months. DISCUSSION: This protocol outlines a randomised controlled trial to investigate whether modified therapies are cost-effective and improve quality of life for people who repeatedly self-harm. Few interventions are proven to be deliverable in the NHS for this population. This study is strengthened by the involvement of qualified mental health workers experienced in managing risk as therapists. TRIAL REGISTRATION: Registered on August 03, 2021. IRAS number: 297939. ISRCTN: https://doi.org/10.1186/ISRCTN73357210 . REC reference: 21/EE/0145. SPONSOR: University of Leeds.
引用
- Farley K, Copsey B, Wright-Hughes A, et al. Randomised controlled trial of a psychotherapeutic intervention to improve quality of life and other outcomes in people who repeatedly self-harm: FReSH START study protocol. Trials. 2024. PMID: 39187855. doi:10.1186/s13063-024-08369-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。